{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:33Z","timestamp":1787502993149,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/00592"],"award-info":[{"award-number":["PI20\/00592"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00164"],"award-info":[{"award-number":["PI23\/00164"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejim.2025.106695","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:23:32Z","timestamp":1767788612000},"page":"106695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9204-9888","authenticated-orcid":false,"given":"R","family":"Torres-Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-8972","authenticated-orcid":false,"given":"L","family":"Teruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-833X","authenticated-orcid":false,"given":"MA","family":"S\u00e1nchez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-6260","authenticated-orcid":false,"given":"P","family":"Cerd\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-5330","authenticated-orcid":false,"given":"E","family":"Gamund\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1303-9584","authenticated-orcid":false,"given":"P","family":"Pel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Moreno-Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Iriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Portillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"G\u00f3mez-Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-4307","authenticated-orcid":false,"given":"J","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-804X","authenticated-orcid":false,"given":"A","family":"Riera-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.106695_bib0001","unstructured":"The portal for rare diseases and orphan drugs, Orphanet. Available from: https:\/\/www.orpha.net\/consor\/cgi-bin\/index.php [Accessed 22 Jul 2025]."},{"key":"10.1016\/j.ejim.2025.106695_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2015.00001","article-title":"Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era","volume":"6","author":"McDonald","year":"2015","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.ejim.2025.106695_bib0003","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2025.106695_bib0004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ejim.2025.106695_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jmg.2005.030833","article-title":"Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease","volume":"43","author":"Abdalla","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejim.2025.106695_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/GIM.0b013e31802d8373","article-title":"Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network","volume":"9","author":"Lesca","year":"2007","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0007","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/jcm9010082","article-title":"Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings","volume":"9","author":"Mora-Luj\u00e1n","year":"2019","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ejim.2025.106695_bib0008","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s00261-018-1671-4","article-title":"Liver involvement in hereditary hemorrhagic telangiectasia","volume":"43","author":"Buscarini","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10.1016\/j.ejim.2025.106695_bib0009","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.ejim.2025.106695_bib0010","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ejim.2025.106695_bib0011","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association\/American stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0012","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-019-1172-8","article-title":"Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry","volume":"14","author":"Riera-Mestre","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.ejim.2025.106695_bib0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11239-023-02839-1","article-title":"Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia","volume":"56","author":"Virk","year":"2023","journal-title":"J Thromb Thrombolysis"},{"issue":"24","key":"10.1016\/j.ejim.2025.106695_bib0014","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis","volume":"65","author":"DR","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ejim.2025.106695_bib0015","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106695_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012812","article-title":"Antithrombotic management after left atrial appendage closure: current evidence and future perspectives","volume":"16","author":"Mesnier","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.ejim.2025.106695_bib0017","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jcin.2023.06.022","article-title":"3-year outcomes from the amplatzer amulet left atrial appendage occluder randomized controlled trial (Amulet IDE)","volume":"16","author":"Lakkireddy","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"36","key":"10.1016\/j.ejim.2025.106695_bib0018","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.106695_bib0019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.thromres.2023.04.017","article-title":"Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review","volume":"226","author":"Zhang","year":"2023","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtha.2022.09.003","article-title":"Al-Samkari H. Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia","volume":"21","author":"Virk","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.ejim.2025.106695_bib0021","doi-asserted-by":"crossref","first-page":"W163","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0022","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"Peer review committee members. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.106695_bib0023","doi-asserted-by":"crossref","DOI":"10.4244\/EIJV12SXA10","article-title":"Left atrial appendage closure: patient, device and post-procedure drug selection","volume":"12","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ejim.2025.106695_bib0024","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"7-8","key":"10.1016\/j.ejim.2025.106695_bib0025","first-page":"950","article-title":"Hereditary hemorrhagic telangiectasia and atrial fibrillation - percutaneous left atrial appendage closure as an alternative strategy for anticoagulation","volume":"83","author":"Grygier","year":"2025","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.ejim.2025.106695_bib0026","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carrev.2022.04.005","article-title":"Left atrial appendage occlusion in hereditary haemorrhagic telangiectasia patients (Rendu Osler Syndrome) with non-valvular atrial fibrillation: prevention of cardioembolic events while avoiding the long-term risks of oral anticoagulation","volume":"43","author":"Cepas-Guillen","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"issue":"6","key":"10.1016\/j.ejim.2025.106695_bib0027","article-title":"Left atrial appendage closure with the use of a WATCHMAN FLX device in a patient with persistent left atrial appendage thrombus","volume":"36","author":"Torres-Saura","year":"2020","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2025.106695_bib0028","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.36740\/WLek201910137","article-title":"Percutaneous left atrial appendage closure in a patient with atrial fibrillation and osler-weber-rendu disease","volume":"72","author":"Gancarczyk","year":"2019","journal-title":"Wiad Lek"},{"issue":"4 Suppl 1","key":"10.1016\/j.ejim.2025.106695_bib0029","article-title":"Chiusura percutanea dell\u2019auricola sinistra in paziente con fibrillazione atriale e malattia di Rendu-Osler-Weber [Percutaneous left atrial appendage closure in a patient with atrial fibrillation and Rendu-Osler-Weber disease]","volume":"20","author":"Bosi","year":"2019","journal-title":"G Ital Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0030","first-page":"49","article-title":"Percutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?","volume":"5","author":"Vorselaars","year":"2015","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.ejim.2025.106695_bib0031","article-title":"Left atrial appendage closure for stroke prevention in patients with atrial fibrillation and hereditary hemorrhagic telangiectasia","volume":"2012","author":"Velthuis","year":"2012","journal-title":"Case Rep Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2025.106695_bib0032","first-page":"604","article-title":"Percutaneous left atrial appendage closure: in a patient with hereditary hemorrhagic telangiectasia and atrial fibrillation","volume":"38","author":"Brenna","year":"2011","journal-title":"Tex Heart Inst J"},{"issue":"6","key":"10.1016\/j.ejim.2025.106695_bib0033","article-title":"Left atrial appendage occlusion: a therapeutic option in a patient with atrial fibrillation and hereditary hemorrhagic telangiectasia","volume":"13","author":"Frade","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0034","doi-asserted-by":"crossref","DOI":"10.5114\/amsad.2017.68657","article-title":"Left atrial appendage occlusion in a patient with hereditary hemorrhagic telangiectasia and atrial fibrillation - a therapeutic option worth considering","volume":"2","author":"Mielczarek","year":"2017","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"3","key":"10.1016\/j.ejim.2025.106695_bib0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/imj.12359","article-title":"Left atrial appendage occlusion with the Watchman device in a patient with paroxysmal atrial fibrillation and intolerance of all forms of anticoagulation due to hereditary haemorrhagic telangiectasia","volume":"44","author":"Spina","year":"2014","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.ejim.2025.106695_bib0036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.23736\/S2724-5683.20.05474-2","article-title":"Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation","volume":"70","author":"Pepe","year":"2022","journal-title":"Minerva Cardiol Angiol"},{"issue":"11","key":"10.1016\/j.ejim.2025.106695_bib0037","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/fca-2022-0043","article-title":"MitraClip\u2122 implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient","volume":"18","author":"D'Alessandro","year":"2022","journal-title":"Future Cardiol"},{"key":"10.1016\/j.ejim.2025.106695_bib0038","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2023.07.001","article-title":"Antiplatelet and anticoagulant therapies in hereditary hemorrhagic telangiectasia: A large French cohort study (RETROPLACOTEL)","volume":"229","author":"Grobost","year":"2023","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.ejim.2025.106695_bib0039","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"von Haehling","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.ejim.2025.106695_bib0041","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1538-7836.2008.03212.x","article-title":"Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice","volume":"7","author":"Meyer","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"15","key":"10.1016\/j.ejim.2025.106695_bib0042","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2025.15440","article-title":"Remote screening for asymptomatic atrial fibrillation: The AMALFI randomized clinical trial","volume":"334","author":"Wijesurendra","year":"2025","journal-title":"JAMA"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525005722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525005722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:11:30Z","timestamp":1780139490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525005722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"alternative-id":["S0953620525005722"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106695","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage closure in patients with hereditary hemorrhagic telangiectasia and atrial fibrillation: a prospective study and systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.106695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106695"}}